Analyzing how degenerative spinal disease affects walking
Official title: Gait Analysis and Degenerative Spine
Run by Universidade Nova de Lisboa · NCT06335095 · Data updated 2026-11-12
This study looks at how degenerative spinal disease affects walking in people to see what changes happen as the disease progresses and with treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 85 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Universidade Nova de Lisboa Academic / other |
| Locations | 1 site (Lisbon) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | September 2025 |
| Study ends | September 2026 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT06335095 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 50 to 85 years with a clinical diagnosis of spinal disease lasting more than three months.
✕Probably not a fit
Patients with previous spine surgery, spinal instability, or significant neurological or orthopedic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to analyze the biomechanics of individuals suffering from degenerative spinal disease. It focuses on identifying the biomechanical variables impacted by the disease and how these variables change with disease progression and treatment. Participants will be monitored using kinematic sensors to gather data on their gait patterns. The findings could provide insights into the relationship between spinal degeneration and mobility.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of gait issues in patients with degenerative spinal disease.
How similar studies have gone: While similar studies have explored gait analysis in spinal conditions, this specific observational approach focusing on biomechanical variables is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 50 and 85 years * Diagnosis of spinal disease by clinical and imagiological criteria * More than 3 months duration of disease * Ability to give consent * Fluent portuguese speaker Exclusion Criteria: * Previous spine surgery * Spinal instability * Neurological disease that might interfere with walking * Known orthopedic conditions that causes significant gait impairment * Dementia or development disorder with cognitive impairment * Inability to give consent
Where it's running
-
Hospital da Luz Setúbal
Lisbon, Portugal Recruiting
Study contacts
- Study coordinator: Nuno A.R. Cristino
- Email: nuno.cristino.ext@nms.unl.pt
- Phone: +351217104400
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-Term safety and performance of the IntraSPINE interlaminar implant for degenerative lumbar spine disease
This study follows up patients who previously received IntraSPINE implants to see how their symptoms and imaging look about 9 years later.
-
Ultrasound-guided Pharmacopuncture for Spinal Pain in Korea
This registry follows patients with spinal pain to see if ultrasound-guided pharmacopuncture is safe and helps reduce pain.
-
Fecal microbiota transplantation for treating axial spondyloarthritis
This study is testing if a treatment using gut bacteria from healthy donors can help people with axial spondyloarthritis who aren't feeling better with their current medications.
-
Advanced spinal radiation therapy using MR imaging
This study is testing a new type of radiation therapy for spinal tumors that uses advanced imaging to see if it can better control the disease and improve patients' quality of life.
-
Gene expression profiles in spinal tuberculosis
This study is trying to see if different gene patterns in spinal tuberculosis can help doctors better understand and treat the disease, especially in people with HIV.
-
OssiMend BA for posterolateral instrumented lumbar fusion
This trial will try OssiMend Bioactive Moldable as the bone graft in adults having instrumented posterolateral lumbar fusion for degenerative disc disease to see if the spine fuses by 12 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.